Microbiome research
ZEISS have established a partnership with microbiome analytics firm Perseus Biomics. The partnership aims to develop an optical technology for microbiome research, specifically the quantitative analysis of the microbiome.
“The microbiome is a field of strong research interest with the potential to fundamentally change our understanding of living systems. Abundance analysis of the microbiome is one key element of this research and Perseus’ innovative optical technology has the potential to enable it at a new level,” said Gerrit Schulte, Head of ZEISS Ventures.
“We have assembled a first-class scientific and R&D team that aims to revolutionise microbiome analysis, making it faster, more precise and more affordable, while opening the way for broad-reach personalised medicine,” said Walid N. Hanna, Executive Chairman of Perseus.
https://www.zeiss.com/
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Picture This: Photo Contest Winners
ESCRS 2025 Refractive and Cataract Photo Contest winners.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.